EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Pseudouridine Synthase 7 in Cancer: Functions, Mechanisms, and Therapeutic Potential

Qiwei Yang iD, Thomas G Boyer, Ayman Al-Hendy iD

Cells · 04.09.2025 · 14 (17) · 1380

DOI: 10.3390/cells14171380 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 04.09.2025. Verfasst von Qiwei Yang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, University of Chicago, Chicago, IL 60637, USA. Hauptthemen laut MEDLINE: Neoplasms, Intramolecular Transferases, Hydro-Lyases. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 103 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NICHD NIH HHS, NIH HHS, National Institutes of Health (NIH) RO1.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pseudouridylation, the most abundant RNA modification, plays a critical role in modulating RNA structure, stability, and function. Among the family of pseudouridine synthases, Pseudouridine Synthase 7 (PUS7) has recently gained attention for its emerging roles in human health and disease. Originally characterized for its function in modifying tRNA and small non-coding RNAs, PUS7 is now recognized as a dynamic regulator of mRNA pseudouridylation, influencing gene expression at the post-transcriptional level. Aberrant expressions or activity of PUS7 have been linked to a variety of pathological conditions, including cancers such as colon cancer, glioblastoma, pancreatic cancer, and neuroblastoma, as well as potential roles in neurodevelopmental disorders and immune regulation. Through mechanisms involving translational reprogramming, stress adaptation, and epitranscriptomic remodeling, PUS7 contributes to disease progression and cellular plasticity. This review summarizes the current understanding of PUS7 biology, its functional relevance in the contexts of cancer progression, and the growing interest in targeting RNA-modifying enzymes for therapeutic intervention. Uncovering the full spectrum of PUS7-mediated pseudouridylation and its downstream effects holds promise for advancing our understanding of RNA-based regulation in human diseases, including gynecological disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsIntramolecular TransferasesHydro-LyasesHumansAnimalsGene Expression Regulation, NeoplasticPseudouridine

Stichwörter der Autor:innen

PUS7PUS7 inhibitorRNA modificationRNA-based targeted therapycancercell proliferationcofactorsepitranscriptomic remodelinggynecological disorderinvasionpathwayspseudouridine synthasespseudouridylationstress adaptationtranslational reprogramming

Substanzen

Intramolecular Transferasespseudouridine synthasesHydro-LyasesPseudouridine

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, University of Chicago, Chicago, IL 60637, USA.
  • Department of Molecular Medicine, UT Health San Antonio, San Antonio, TX 78229, USA.
  • Department of Medical Sciences, Khalifa University, Abu Dhabi P.O. Box 127788, United Arab Emirates.

ORCID-Profile: Qiwei Yang, Ayman Al-Hendy

Förderung

  • NICHD NIH HHS
  • NIH HHS
  • National Institutes of Health (NIH) RO1

Zitieren

APA

Yang, Q., Boyer, T. G., & Al-Hendy, A. (2025). Pseudouridine Synthase 7 in Cancer: Functions, Mechanisms, and Therapeutic Potential. Cells, 14(17), 1380. https://doi.org/10.3390/cells14171380

Vancouver

Yang Q, Boyer TG, Al-Hendy A. Pseudouridine Synthase 7 in Cancer: Functions, Mechanisms, and Therapeutic Potential. Cells. 2025;14(17):1380. doi:10.3390/cells14171380

BibTeX
@article{Yang2025,
  author = {Yang, Qiwei and Boyer, Thomas G and Al-Hendy, Ayman},
  title = {Pseudouridine Synthase 7 in Cancer: Functions, Mechanisms, and Therapeutic Potential},
  journal = {Cells},
  year = {2025},
  volume = {14},
  number = {17},
  pages = {1380},
  doi = {10.3390/cells14171380}
}
Kostenlos starten →